Key facts
- This page summarizes Michael E. Sturmer's Form 4 filing for Progyny, Inc. (PGNY).
- 4 reported transactions and 1 derivative row are listed below.
- Accepted by SEC: 03 Apr 2024, 17:23.
Key filing fact
Ownership activity is grounded in SEC Form 4 disclosures.
Shares, units, or other non-derivative securities reported in this filing.
Award
Sale
Sale
Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.
Award
Additional SEC filing notes
Rule 10b5-1 trading plan
These transactions were reported as open-market trades under a Rule 10b5-1 plan. The plan lets an insider set trading instructions in advance, which can reduce the risk of trading while in possession of material nonpublic information.
Original filing language: transaction made pursuant to a contract, instruction, or written plan intended to satisfy Rule 10b5-1(c).
Footnote F1
Represents the number of shares of Issuer common stock underlying restricted stock units ("RSUs"). This was an annual merit grant made pursuant to the Issuer's 2019 Equity Incentive Plan. Each RSU represents a contingent right to receive one share of Issuer common stock. 25% of the RSUs will vest on March 4, 2025 with the remaining RSUs vesting in equal quarterly installments thereafter through March 4, 2028, subject to the Reporting Person's continued service through each applicable vesting date.
Footnote F2
Shares sold pursuant to a Rule 10b5-1 trading plan entered into on August 31, 2023.
Footnote F3
Represents an annual merit grant made pursuant to the Issuer's 2019 Equity Incentive Plan. 25% of the shares subject to the option will vest on March 4, 2025 with the remaining shares subject to the option vesting in equal quarterly installments thereafter through March 4, 2028, subject to the Reporting Person's continued service through each applicable vesting date.